The table below shows ANAPTYSBIO, INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$234.60M
$91.28M
$17.16M
$10.29M
$63.17M
$75.00M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
-
-
-
$88.80M
$98.50M
$80.03M
SG&A
$50.74M
ANAB annual revenue (10-K history)
ANAPTYSBIO, INC reported annual revenue of $234.60M for fiscal year 2025. That is up 157.0% from $91.28M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $16.68M (FY 2016) to $234.60M. Figures come from the company's audited annual reports as filed with the SEC.